Literature DB >> 17806044

Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever.

Mustafa Aydin Cevik1, Ayşe Erbay, Hürrem Bodur, Selim Sirri Eren, Esragül Akinci, Kenan Sener, Pinar Ongürü, Ayhan Kubar.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a potentially fatal disease affecting multiple organ systems. To determine the association between viral load and severity of CCHF infection, quantitative measurement of CCHF virus was performed using 1-step reverse-transcriptase polymerase chain reaction for 36 patients with CCHF infection. Viral loads ranged from 1.1x10(3) copies/mL to > or = 9.9x10(9) copies/mL. Nine (25%) of 36 patients died. In 8 of the 9 patients with fatal outcomes, viral loads were detected that were > or = 1x10(9) copies/mL, whereas in 25 of the 26 patients with nonfatal outcomes, viral loads were detected that were < 1x10(9) copies/mL (P<.001). A viral load > or = 1x10(9) RNA copies/mL can be considered to predict a fatal outcome with a positive predictive value of 80%, with 88.9% sensitivity and 92.6% specificity. We suggest that viral load is a measure of the severity of CCHF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17806044     DOI: 10.1086/521244

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Crimean-Congo hemorrhagic fever virus activates endothelial cells.

Authors:  Anne-Marie Connolly-Andersen; Guido Moll; Cecilia Andersson; Sara Akerström; Helen Karlberg; Iyadh Douagi; Ali Mirazimi
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

Authors:  P Onguru; S Dagdas; H Bodur; M Yilmaz; E Akinci; S Eren; G Ozet
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever.

Authors:  Ana Saksida; Darja Duh; Branka Wraber; Isuf Dedushaj; Salih Ahmeti; Tatjana Avsic-Zupanc
Journal:  Clin Vaccine Immunol       Date:  2010-05-19

Review 4.  Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.

Authors:  Vanessa N Raabe
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

5.  Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.

Authors:  Dennis A Bente; Judie B Alimonti; Wun-Ju Shieh; Gaëlle Camus; Ute Ströher; Sherif Zaki; Steven M Jones
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

6.  Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.

Authors:  Marko Zivcec; David Safronetz; Dana Scott; Shelly Robertson; Hideki Ebihara; Heinz Feldmann
Journal:  J Infect Dis       Date:  2013-02-15       Impact factor: 5.226

7.  Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF).

Authors:  M Bakır; M G Gözel; I Köksal; Z Aşık; Ö Günal; H Yılmaz; A But; G Yılmaz; A Engin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-12       Impact factor: 3.267

Review 8.  Crimean-Congo hemorrhagic fever: an overview.

Authors:  Serkan Oncü
Journal:  Virol Sin       Date:  2013-07-22       Impact factor: 4.327

9.  Second International Conference on Crimean-Congo Hemorrhagic Fever.

Authors:  Jessica R Spengler; Dennis A Bente; Mike Bray; Felicity Burt; Roger Hewson; Gülay Korukluoglu; Ali Mirazimi; Friedemann Weber; Anna Papa
Journal:  Antiviral Res       Date:  2017-12-02       Impact factor: 5.970

10.  A cynomolgus macaque model for Crimean-Congo haemorrhagic fever.

Authors:  Elaine Haddock; Friederike Feldmann; David W Hawman; Marko Zivcec; Patrick W Hanley; Greg Saturday; Dana P Scott; Tina Thomas; Miša Korva; Tatjana Avšič-Županc; David Safronetz; Heinz Feldmann
Journal:  Nat Microbiol       Date:  2018-04-09       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.